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Through chemical screening, we identified a pyrazolone that reversibly blocked the 
activation of phagocyte oxidase (phox) in human neutrophils in response to tumor necrosis 
factor (TNF) or formylated peptide. The pyrazolone spared activation of phox by phorbol 
ester or bacteria, bacterial killing, TNF-induced granule exocytosis and phox assembly, and 
endothelial transmigration. We traced the pyrazolone’s mechanism of action to inhibition of 
TNF-induced intracellular Ca
 
2
 
 
 
 elevations, and identified a nontransmembrane (“soluble”) 
adenylyl cyclase (sAC) in neutrophils as a Ca
 
2
 
 
 
-sensing source of cAMP. A sAC inhibitor 
mimicked the pyrazolone’s effect on phox. Both compounds blocked TNF-induced activation 
of Rap1A, a phox-associated guanosine triphosphatase that is regulated by cAMP. Thus, TNF 
turns on phox through a Ca
 
2
 
 
 
-triggered, sAC-dependent process that may involve activation 
of Rap1A. This pathway may offer opportunities to suppress oxidative damage during 
inflammation without blocking antimicrobial function.
 
Neutrophils, the most abundant leukocytes
in blood, provide a critical element of host de-
fense. Defects in neutrophil numbers, migration
across endothelium or bactericidal mechanisms
lead to life-threatening infections. At the same
time, neutrophil activation is a major contrib-
utor to inflammatory tissue damage (1). Thus,
it is a goal of antiinflammatory therapy to target
neutrophils, but it is a challenge to do so without
impairing host defense.
Two families of neutrophil products play
key roles in host defense and tissue damage.
Activated neutrophils degranulate to release
antibiotic proteins, including proteases that
degrade connective tissue. Activated neutro-
phils also secrete reactive oxygen intermedi-
ates (ROIs), products of phagocyte oxidase
(phox), a multicomponent enzyme whose cat-
alytic flavocytochrome is a transmembrane
protein of the granules. ROIs contribute di-
rectly to bacterial killing (2) but also promote
proteolytic tissue damage by: triggering K
 
 
 
influx into the phagolysosome, desorbing pro-
teases from their proteoglycan bed (3), acti-
vating neutrophil proteases (4) and matrix
metalloproteinases (5), inactivating antiproteases
(1), and activating NF-
 
 
 
B and AP1, transcrip-
tion factors for numerous genes with proin-
flammatory products, including chemokines
that attract neutrophils. Thus, inhibition of neu-
trophil ROI production would be expected to
reduce inflammatory proteolysis through mul-
tiple mechanisms.
Maximal neutrophil activation can be in-
duced artificially with PMA or physiologically
by inflammatory peptides and proteins, such
as TNF (6). The soluble, physiologic agonists
are far more effective if the neutrophils are ad-
herent to extracellular matrix proteins by way
of integrins (7). Adherence (8) and TNF (9)
combine to trigger oscillatory elevations of in-
tracellular Ca
 
2
 
 
 
, which take the form of spa-
tially restricted, moving waves in neutrophils
responding to N-formylpeptide (10). How-
ever, it remains unclear how TNF activates
neutrophils. To help answer this question, we
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Figure 1. Identification of compounds that inhibit the neutrophil 
respiratory burst in response to TNF.
 
 (A) Chemical structures and con-
centration-response curves. Compounds were added at 37
 
 
 
C for 30 min 
before stimulation with TNF (red squares) or PMA (black triangles). H
 
2
 
O
 
2
 
 
release at 90 min is displayed as percentage of H
 
2
 
O
 
2
 
 release seen with
TNF or PMA in the presence of the vehicle, DMSO. (B) Reversibility. 
Neutrophils incubated with DMSO (D), 
 
2
 
, or 
 
5
 
 were left unmanipulated 
(black bars) or washed (open bars) with buffer before both sets were
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decided to seek chemical inhibitors of TNF-induced neu-
trophil activation, and attempted to identify their mecha-
nisms of action.
 
RESULTS AND DISCUSSION
 
We screened 15,000 compounds for those that blocked H
 
2
 
O
 
2
 
release by TNF-treated, adherent neutrophils, but spared H
 
2
 
O
 
2
 
release when the same cells were triggered by PMA. The PMA
counterscreen allowed us to exclude compounds that were
toxic, inhibited phox or protein kinase C, or interfered with the
assay. Four compounds were both selectively inhibitory and
consistently effective with neutrophils from different donors.
We chose compound 
 
2
 
 (2-[3-chloro-phenyl]-5-phenyl-2,4-
dihydro-pyrazol-3-one) for analysis here. The others (
 
1
 
, 
 
3
 
,
and 
 
4
 
) work in different ways, as will be reported elsewhere
(Han et al., unpublished data). 
 
5
 
 ((3-morpholin-4-yl-pro-
pyl)-(5,6,7,8-tetrahydro-benzo[4,5]thieno[2,3-
 
d
 
]pyrimidin-4-
yl)-amine) shares its core structure with 
 
1
 
 and 
 
3
 
, but had no
effect on H
 
2
 
O
 
2
 
 release and was used as a control. Concentra-
tion-response curves of 
 
2
 
, using neutrophils from three donors,
yielded a mean 50% inhibitory concentration (IC
 
50
 
) 
 
 
 
 SEM of
1.6 
 
 
 
 0.4 
 
 
 
M for H
 
2
 
O
 
2
 
 release (Fig. 1 A). A new screen of
1,100 congeners of 
 
2
 
 identified 
 
2
 
 
 
 (5-methyl-4-[(2-methyl-
quinolin-8-ylamino)-methyl]-2-phenyl-2,4-dihydro-pyrazol-
3-one), with an IC
 
50
 
 of 24 
 
 
 
 6 nM (Fig. 1 A). Because 
 
2
 
 
 
 was
identified after most of these studies were completed, we focus
here on 
 
2
 
. At 5 
 
 
 
M, 
 
2
 
 yielded 
 
 
 
95% inhibition of TNF-trig-
gered H
 
2
 
O
 
2
 
 release with cells from all donors tested. This con-
centration was used for all further experiments.
When neutrophils were treated with 
 
2
 
 and then
washed, they regained responsiveness to TNF (Fig. 1 B).
The cells remained susceptible to inhibition when
 
 2
 
 was
added back (Fig. 1 B). Thus, inhibition by 
 
2
 
 was fully re-
versible. When we added 
 
2
 
 to neutrophils that already
were releasing H
 
2
 
O
 
2
 
 in response to TNF, the respiratory
burst slowed quickly (Fig. 1 C). Thus, the process inhibited
by 
 
2
 
 was needed to launch the TNF-triggered respiratory
burst and to sustain it.
Next, we tested the effects of 
 
2
 
 on neutrophils’ responses
to bacteria and to the major neutrophil stimulant released
by 
 
Escherichia coli,
 
 formylated methionyl-leucyl-phenylalanine
(fMLF). H
 
2
 
O
 
2
 
 release triggered by fMLF was blocked by 
 
2
 
.
However, 
 
2
 
 did not inhibit H
 
2
 
O
 
2
 
 release triggered by 
 
Salmo-
nella enterica
 
 var. Typhimurium, and only reduced slightly
the respiratory burst that was elicited by 
 
Listeria monocytog-
enes
 
 (Fig. 1 D). 
 
2
 
 also did interfere with the killing of these
pathogens by neutrophils (Fig. S1, available at http://www.
jem.org/cgi/content/full/jem.20050778/DC1).
Degranulation delivers the phox flavocytochrome to
phagosomal and plasma membranes (11) where the cytosolic
components of phox are recruited. Therefore, we consid-
ered that 
 
2
 
 might block activation of phox by blocking de-
granulation. However, 
 
2
 
 did not block TNF-induced exo-
cytosis of the specific granule marker, lactoferrin, and only
inhibited slightly the release of the azurophil granule marker,
myeloperoxidase (Fig. 1 E).
The large-scale respiratory burst triggered by TNF or
fMLF requires that neutrophils spread on extracellular matrix
(6, 7). Pretreatment with 
 
2
 
 allowed neutrophils to spread
normally on serum-coated glass in response to PMA. With
TNF as a stimulus in 
 
2
 
-pretreated cells, spreading was initi-
ated, which suggested that 
 
2
 
 did not interfere with binding
of TNF or transmission of some signals to the cytoskeleton.
However, 
 
2
 
 caused TNF-triggered spreading to halt prema-
turely, which suggested inhibition of a later stage in TNF
signaling (Fig. 2 A).
Interference with spreading of neutrophils in response to
TNF raised the question of whether 
 
2
 
 might block migra-
tion across endothelium—the process by which neutrophils
enter tissues. However, pretreatment of neutrophils with 
 
2
 
blocked neither the adhesion of the cells to, nor their migra-
tion across, monolayers of TNF-activated human umbili-
cal vein endothelial cells (HUVECs; Fig. 2, available at
http://www.jem.org/cgi/content/full/jem.20050778/DC1).
Moreover, pretreatment of HUVECs with 
 
2
 
 did not influ-
ence the integrity of the monolayer nor the cells’ ability to
respond to TNF by supporting adhesion and transmigration
of untreated neutrophils (unpublished data). Similarly, a 2-d
incubation with 
 
2
 
 did not affect the morphology or adher-
ence of primary mouse peritoneal exudate macrophages, nor
the ability of TNF to synergize with IFN-
 
 
 
 in inducing
them to release nitric oxide (unpublished data). These exper-
iments demonstrated that 
 
2
 
 inhibited only a selective as-
pect(s) of TNF signal transduction.
Neutrophil responses to TNF require protein tyrosine
phosphorylation involving Syk (12, 13); Src family kinases,
Hck and Fgr (14); and Pyk2 (15, 16). However, treatment of
adherent neutrophils with 
 
2
 
 had little impact on overall
protein tyrosine phosphorylation induced by TNF (Fig.
S3 A, available at http://www.jem.org/cgi/content/full/
jem.20050778/DC1). Nor did 
 
2
 
 inhibit recombinant Src
(Fig. S3 B), Syk (Fig. S3 C), or TNF-induced (auto)phos-
phorylation of Pyk2 on tyrosine 402 (Fig. S3 D), which is
critical for Pyk2’s kinase activity (17).
Cytosolic components of phox—p40
 
phox
 
, p47
 
phox
 
, and
p67
 
phox
 
—form a 
 
M
 
r
 
 
 
 
 
240,000 complex (18) in resting neu-
plated and stimulated with TNF. Other neutrophils from which the com-
pounds had been washed off were reexposed to the compounds (red 
hatched bars). (C) Influence of 2 after the onset of respiratory burst. 
At indicated times, 2 was added to neutrophils already undergoing a
TNF-triggered respiratory burst (RB). (D) Inhibition by 2 of the respiratory 
burst triggered by fMLF but not by bacteria. Neutrophils were preincu-
bated with DMSO (D), 2, or 5 and not stimulated (NS) or stimulated with 
fMLF (100 nM), L. monocytogenes (L.m.) or S. enterica. (S.t.) (S.H2O2 release
is depicted at the time it reached plateau. (A–C) means   SEM for trip-
licates. (E) Impact on degranulation. Neutrophils were stimulated and
their supernates were assayed for lactoferrin (LTF) and myeloperoxidase 
(MPO) as a percent of that released in the absence of compound. Each dot 
is the mean of duplicates in one experiment. Horizontal bars are group 
means. TNF and PMA were used at 100 ng/ml in all figures.NEUTROPHIL ACTIVATION BY TNF | Han et al. 356
trophils, with p47phox serving as an essential adaptor. The
complex translocates to the membrane upon activation. 2 had
no effect on TNF-induced translocation of p47phox to the
membrane (Fig. 3 A). Because 2 inhibited neither the assem-
bly of phox (Fig. 3 A) nor its catalytic activity when triggered
by PMA (Fig. 1 A), we hypothesized that 2 might interfere
with a later stage in phox activation, namely, TNF-dependent
activation of one of the guanosine triphosphatases bound to
phox, Rac2 (19) or Rap1A (20). Rac2-deficient neutrophils
have severe migration defects (21), whereas 2-treated neutro-
phils migrated normally (Fig. S2). Thus, Rac2 was unlikely to
be the locus of regulation by 2, and we focused on Rap1A.
Rap1A is bound stoichiometrically to the phox flavocy-
tochrome in a guanosine triphosphate (GTP)– and phos-
phorylation-dependent manner (22). Treatment of neu-
trophils with fMLF or GM-CSF activated Rap1A (i.e.,
converted it to the GTP-bound state; reference 23). We
found that TNF treatment of adherent neutrophils also acti-
vated Rap1A, and 2 blocked TNF-induced Rap1A activa-
tion (Fig. 3 B).
Rap1A can be activated by a guanine nucleotide ex-
change protein, exchange protein directly activated by
cAMP (Epac; references 24, 25). The cAMP that activates
Epac can arise from the long-studied G protein–regulated,
transmembrane adenylyl cyclases (tmACs) or from a recently
discovered nontransmembrane (“soluble”) adenylyl cyclase,
sAC, which is regulated by intracellular Ca2  and bicarbon-
ate (26, 27). We considered tmACs unlikely candidates for
neutrophil activation because their pharmacologic stimula-
tion inhibits most neutrophil functions, including TNF-
induced activation of phox (28). Thus, we asked if neutro-
phils contain sAC.
Immunoblot revealed sAC in highly purified neutrophil
preparations (Fig. 4 A). Neutrophils were the source of the
immunoreactivity because they were stained uniformly and
specifically by three mAbs, each directed against a different
epitope of sAC, as shown for one mAb in Fig. 4 B. The
granular pattern of staining raised the possibility that sAC
may reside near phox, but definitive analysis of sAC’s subcel-
lular localization awaits immuno-electron microscopy.
Next, we selected pharmacologic reagents to distinguish
between possible sources of cAMP in a mammalian cell. A
chemical screen identified a specific inhibitor of recombinant
human sAC, 2-(1H-benzoimidazole-2-ylsulfanyl)-propionic
acid (5-bromo-2-hydroxy-benzylidene)-hydrazide (KH7)
that spares tmACs (29). Reciprocally, we determined a con-
centration range in which 2 ,5  dideoxyadenosine (ddAdo)
acts as a selective inhibitor of tmACs, sparing sAC. Like 2,
KH7 inhibited TNF-triggered activation of Rap1A (Fig. 3
B), and suppressed TNF-triggered H2O2 release with an
IC50   SEM of 4.7   0.3  M while sparing PMA-triggered
H2O2 release (Fig. 4 C). In contrast, the selective inhibitor of
tmACs, ddAdo, had no effect on the activation of Rap1
(Fig. 3 B) or on the TNF-induced respiratory burst (Fig. 4
C). KH7 seemed to elicit a small degree of Rap1A activation
by itself, the basis of which is not known. These findings
suggest that TNF-triggered activation of Rap1 is mediated
by sAC, not by tmACs.
Figure 2. Impact of inhibitors on neutrophil spreading. Neutrophils 
were plated on FBS-coated glass cover slips, incubated or not with each 
compound at 37 C for 30 min before stimulation with TNF, PMA, or an 
equal volume of buffer (no stimulus, NS). After 30 min, the cells were fixed 
and photographed with phase-contrast microscopy (100 ). 
Figure 3. Impact of inhibitors on components of the phox complex. 
(A) Translocation of p47phox to membranes. Neutrophils were incubated with 
DMSO (D) or 2 at 37 C for 30 min and stimulated with TNF (T), PMA (P), or 
buffer (NS). After 40 min, cells were lysed and membrane fractions collected 
by ultracentrifugation, separated by SDS-PAGE, and Western-blotted with 
anti-p47phox antibody. (B) Activation of Rap1A. Lysates of neutrophils that 
had been pretreated for 30 min with DMSO (D), 2, KH7 (25  M), or the 
tmAC inhibitor ddAdo (25  M), and then stimulated for 30 min with TNF or 
buffer (NS) alone were incubated with agarose beads coupled to recombi-
nant RalGDS-Rap binding domain to affinity purify GTP-bound Rap1A. 
Beads were boiled in SDS sample buffer and the supernate subjected to 
SDS-PAGE and Western blot with anti-Rap1A antibody (top row). Western 
blot of total cell lysates (bottom row) served as a control.JEM VOL. 202, August 1, 2005 357
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Unlike KH7, 2 did not inhibit recombinant sAC (data
not shown). Thus, we hypothesized that 2 might block a
step upstream of sAC, such as TNF-induced elevation of in-
tracellular Ca2 . We first demonstrated that neutrophil sAC
could respond to elevations of intracellular Ca2 . Ionomy-
cin, a Ca2  ionophore, induced production of cAMP in
neutrophils, and the ionomycin-induced cAMP production
was blocked by the sAC inhibitor, KH7 (Fig. 4 D); this indi-
cated that sAC was responsible for the increase in cAMP. 2
had no effect on the ionomycin-induced production of
Figure 4. sAC as a critical element of TNF signaling in neutro-
phils. (A) Western blot. Neutrophils were lysed and subjected to SDS-PAGE/
Western blot with anti-sAC mAb R21. Lane 1 (control): lysate of Chinese 
hamster ovary cells transfected with sperm isoform of sAC. Lanes 2, 3: 
neutrophil lysates treated without (lane 2) or with (lane 3) protease 
inhibitor diisopropylfluorophosphate. (B) Immunofluorescence micros-
copy. Neutrophils were stained with or without biotinylated anti-sAC 
mAb R41 followed by streptavidin-Alexafluor 594. (C) Effects of sAC 
inhibitor KH7 and tmAC inhibitor ddAdo on the respiratory burst. Com-
pounds were added to adherent neutrophils at 37 C for 30 min before 
stimulation with TNF (red squares) or PMA (black triangles). (D) sAC 
activity in neutrophils (5   106/well) preincubated 30 min with the 
phosphodiesterase inhibitor, isobutylmethylxanthine (100  M) and 
DMSO (D), 2, or KH7, then stimulated with ionomycin (1  M). cAMP 
accumulation was measured at 0 min and 2 min after stimulation. 
(E) Impact on TNF-triggered Ca2  elevation in Fluo-3/AM-loaded neu-
trophils. Left panels are pseudocolored images of adherent neutrophils 
pretreated with DMSO (D) or 2 for 30–60 min and then treated with 
TNF or no stimulus (NS). Average relative fluorescence intensity (RFI) for 
all cells in similar microscopic fields is plotted as a function of time on 
the right. Arrow marks addition of TNF. Some cells were pretreated with 
KH7 (25  M) as indicated. (F) Speculative model.NEUTROPHIL ACTIVATION BY TNF | Han et al. 358
cAMP, which confirmed that 2 does not inhibit endogenous
sAC. To test whether 2 blocked TNF-induced Ca2  eleva-
tion, we loaded adherent neutrophils with the Ca2 -sensi-
tive fluorochrome, Fluo3/AM, and studied their fluores-
cence by way of videomicroscopy. TNF triggered an almost
instantaneous elevation of intracellular Ca2  that persisted
throughout the observation period ( 2 min; Fig. 4 E). The
elevation seemed to be nearly constant when expressed as
average fluorescence intensity per microscopic field in fields
that contained hundreds of cells. However, inspection of in-
dividual cells revealed asynchronous, irregular oscillations, as
reported (30). Pretreatment of the cells with 2 substantially
suppressed the TNF-induced increase in intracellular Ca2 
(Fig. 4 E), although 2 had no effect on Ca2  elevation that
was induced artificially by ionomycin (not depicted). In con-
trast, pretreatment with KH7 did not suppress the TNF-
induced increase in intracellular Ca2  (Fig. 4 E). We pro-
pose that 2 be named “neucalcin-1” for neutrophil calcium
inhibitor, and 2  be named “neucalcin-2.”
These findings outline a pathway for TNF signal trans-
duction that is distinct from the known routes that lead to
transcriptional regulation and apoptosis. Fig. 4 F outlines a
speculative model: exposure of adherent neutrophils to TNF
leads to elevation of intracellular Ca2  (9, 30), which stimu-
lates sAC (26, 27) to generate cAMP. The elevated cAMP
causes activation of Rap1A, perhaps by way of Epac. Acti-
vated Rap1A may turn on phox, whose components have
been assembled in response to TNF, fMLF, and other solu-
ble, physiologic agonists. This proposed pathway is indepen-
dent of the previously described TNF signaling cascade in-
volving phosphatidylinositol 3-kinase and tyrosine kinases
that mediates degranulation and the degranulation-depen-
dent assembly of phox (13, 16). The sAC-dependent and
sAC-independent pathways seem to converge on phox. The
two chemically distinct inhibitors used in this study, neucal-
cin and KH7, seem to act at two different points in the sAC-
dependent pathway (Fig. 4 F). However, further work is
needed to identify the molecular target of neucalcins, the
means by which TNF triggers the elevation of intracellular
Ca2 , the role (if any) of Epac, and the participation and
mechanism of Rap1A in the activation of phox.
It may seem paradoxical that in previous studies, direct
measurement of cAMP levels in TNF-treated neutrophils
did not reveal an elevation; on the contrary, TNF prolonged
a decline in cAMP that was induced when neutrophils ad-
hered to biologic surfaces (28). Those observations can be
reconciled with our new observations by proposing that the
elevations of cAMP that are required to sustain the activa-
tion of phox by TNF are spatially confined and quantita-
tively insufficient to nullify the decrease in cAMP that pro-
ceeds at the same time in a larger cellular compartment.
Opposing effects of cAMP have been reported on pro-
tein kinase B, depending on whether the cAMP effector is
protein kinase A or Epac (31). A similar situation may per-
tain to Rap1A. Pharmacologically induced, global, sustained
elevations in cAMP that suppress neutrophil functions are
likely to activate protein kinase A, which can phosphorylate
Rap1A and block its association with phox (22). In contrast,
because TNF-induced Ca2  elevations in neutrophils are os-
cillatory (9, 30) and probably localized (10), sAC-mediated
production of cAMP and the ensuing activation of Rap1A
also may be oscillatory and localized. It has been argued that
Rap1A must undergo cycles of association with, and dissoci-
ation from, phox to sustain phox activity (32, 33). The ki-
netic studies in Fig. 1 C are consistent with the concept that
sustained H2O2 release in response to TNF may require re-
petitive Rap1A activation.
Thus, we have identified a new enzyme in neutrophils,
sAC; a new pathway for TNF signal transduction, centered
on sAC; the ability of endogenous sAC to sense Ca2  eleva-
tions; a possible functional role for the Ca2  elevations in ad-
herent, TNF-stimulated neutrophils; evidence that cAMP
can not only inhibit but also activate neutrophils; and chem-
ical agents, neucalcins, that may serve as tools to discover
how TNF leads to Ca2  elevation. These findings help to
generate a list of targets whose inhibition might allow selec-
tive intervention in neutrophil functions.
Blocking nonbacterial activation of phox might be a
more effective way to reduce neutrophil-dependent proteol-
ysis of tissue than attempting to inhibit individual proteases.
The latter approach suffers from the redundancy of proteases
released by neutrophils, and those produced by other cells
but activated, in part, by neutrophils. In contrast, selective
interference with the inflammatory activation of phox may
retard the release of neutrophil proteases from their pro-
teoglycan matrix in the lysosomes (3); prevent the oxidative
activation of neutrophil proteases (4); blunt the oxidative
activation of matrix metalloproteinases (5); diminish the
oxidative inactivation of the major antiproteases secretory
leukocyte protease inhibitor,  1-antiprotease and  2 macro-
globulin (1); and diminish the oxidative contribution to
NF- B– and AP1-dependent expression of chemokines and
other inflammatory mediators.
In sum, this work shows that it is feasible to block the
activation of phox by inflammatory factors without inter-
fering with neutrophil migration or phox-dependent kill-
ing of ingested bacteria.
MATERIALS AND METHODS
Cells.  All cells were used under Institutional Review Board–approved
protocols. Neutrophils were isolated from heparinized (10 U/ml) blood of
healthy, consenting adult donors to  95% purity using Polymorphprep
(Axis-Shield PoC AS) according to the manufacturer’s instructions. Con-
taminating erythrocytes were lysed by hypotonic shock for 45 s with 0.2%
saline. Neutrophils were resuspended in Krebs Ringer phosphate with glu-
cose (KRPG) formulated as described (34). HUVECs were isolated from
umbilical cords and cultured as described (35). Peritoneal macrophages were
isolated from C57BL/6 mice 4 d after injection of 2 ml of thioglycollate
broth (4%) and cultured as described (34).
H2O2 release and degranulation. The neutrophil respiratory burst was
measured as described (34). In brief, 96-well flat-bottomed plates (Primaria,
Falcon) were coated with 50  l/well of FBS in 5% CO2 in air at 37 C for at
least 1 h and washed three times with 0.9% saline. 1.5   104 neutrophilsJEM VOL. 202, August 1, 2005 359
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were added to triplicate wells containing 100  l of reaction mixture (2.4
nmol scopoletin, 0.5  g horseradish peroxidase, and 1 mM NaN3) and
stimulated with either buffer control, TNF (Preprotech) or PMA, each at
100 ng/ml. The reduction of scopoletin by H2O2 was recorded every 15
min on a plate-reading fluorometer until H2O2 release reached plateau. The
amount of H2O2 released was calculated as described (34). The supernate
from the H2O2 release assay with 1.5   104 neutrophils was used to mea-
sure degranulation using lactoferrin or myeloperoxidase ELISA kit (Oxis In-
ternational, Inc.). Spontaneous cell death from the same supernate was mea-
sured using Cytotoxicity Detection Kit (Roche Molecular Biochemicals),
an assay for lactate dehydrogenase. The total cell content of lactoferrin, my-
eloperoxidase, and lactate dehydrogenase was determined after lysing cells
with 1% Triton X-100.
Automated assay screening. A collection of 15,000 compounds with
drug-like characteristics from ChemDiv Labs was screened robotically in the
High Throughput Screening Facility at The Rockefeller University to iden-
tify specific inhibitors of TNF-triggered H2O2 release in human neutrophils.
KH7 was identified in the same library during an independent screen for in-
hibition of sAC. H2O2 release was measured as above with the following
modifications. Black instead of clear, 96-well tissue culture plates (Falcon,
catalog number 353945) were used to reduce background fluorescence as
measured in a Perkin-Elmer Fusion microplate reader. A Titertek Multidrop
96/384 dispenser was used for bulk reagent dispensing, Bi-Tek Elx 405 Se-
lect system was used for plate washing, and a PerkinElmer MiniTrakV liquid
handling dispenser was used for the delivery of compound aliquots to each
well. Percent inhibition by each compound was calculated using the for-
mula: ([T0- T90]   100)/(Tc0-Tc90), where T0 and T90 are fluorescence
readings at each well at 0 and 90 min, respectively, and Tc0 and Tc90 are
the mean fluorescence readings in the compound-free control wells at 0 and
90 min, respectively. Compounds that showed  90% inhibition of the
TNF-triggered respiratory burst were retested with TNF and PMA as stim-
uli to eliminate nonspecific, toxic chemicals and protein kinase C inhibitors.
Test of reversibility of inhibition. Neutrophils were incubated with
each compound at 37 C for 30 min in FBS-coated tubes (Falcon), washed
twice with cold KRPG (5 min each at 4 C), and plated in 96-well plates be-
fore immediate stimulation with TNF or an equivalent volume of KRPG
buffer as a control. On a separate plate, compounds were added back to the
neutrophils from which compounds had been washed off, and cells were stim-
ulated to evaluate the neutrophils’ capacity to respond. Neutrophils incubated
with each compound without washing also were stimulated for comparison.
Bacteria-triggered respiratory burst. Neutrophils were incubated with
DMSO or each compound for 30 min at 37 C and exposed to 10% autolo-
gous serum-opsonized S. enterica var. Typhimurium (14028s; American
Type Culture Collection) or L. monocytogenes (104035; American Type
Culture Collection) at a multiplicity of infection of 0.5 bacteria per neutro-
phil. H2O2 release was measured as described before.
Bacterial killing. Neutrophils were preincubated with or without 2 for
30 min at 37 C and exposed to 10% autologous serum-opsonized S. enterica
var. Typhimurium (14028s; American Type Culture Collection) or L.
monocytogenes (15323; American Type Culture Collection) at a multiplicity
of infection of 0.5 bacteria per neutrophil. Neutrophils were lysed at the in-
dicated times with 1% sodium deoxycholate for assays with Salmonella or 1%
Triton X-100 for assays with Listeria. Bacteria recovered from each condi-
tion were grown in Luria Bertani agar plates at 37 C overnight, and the col-
onies were counted.
Morphology. Acid-washed glass cover slips were placed in a 12-well tis-
sue culture plate, coated with FBS in 5% CO2 at 37 C for at least 1 h, and
washed three times with 0.9% saline. Neutrophils (2   106) were added to
each well in 1 ml of reaction mixture, and incubated or not with each com-
pound at 37 C for 30 min before stimulation with TNF (100 ng/ml), PMA
(100 ng/ml), or an equal volume of KRPG. Cells were fixed with 2% para-
formaldehyde and 3.7% formaldehyde buffer, and photographed through a
phase-contrast microscope. Results are typical of those based on inspecting
living cells at 15-min intervals over 2 h.
Transendothelial migration assay. HUVECs were isolated and cul-
tured in M199 medium (GIBCO BRL) supplemented with 20% normal
human serum, penicillin, and streptomycin as described (35). Experiments
used cells at passage two that were cultured on hydrated type I collagen gels
in 96-well plates. Where shown, HUVECs were stimulated with TNF (50
pg/ml) in 5% CO2 at 37 C for the final 12–18 h. Neutrophils were isolated
from the peripheral blood of healthy adult volunteers by density gradient
sedimentation in a discontinuous gradient of Ficoll (GE Healthcare) and
Histopaque (Sigma-Aldrich), washed in Hanks’ balanced salt solution with
0.1% human serum albumin, resuspended to 0.5   106 cells/ml, and added
to HUVEC monolayers. Test compounds were incubated with the neutro-
phils at room temperature for 30 min before transendothelial migration, and
allowed to remain during the duration of the assay. After neutrophils were
allowed to transmigrate for 30 min at 37 C, nonadherent neutrophils were
washed off with PBS, and the remaining adherent and transmigrated cells
were fixed with the endothelial monolayer by incubation overnight in 2.5%
glutaraldehyde (Electron Microscopy Sciences) in 0.1 sodium cacodylate
buffer. HUVECs and neutrophils were stained differentially with Wright-
Giemsa stain, and adherent and transmigrated cells were counted in multiple
fields from the six replicates of each condition tested. Total adhesion was
calculated as the total number of adherent and transmigrated cells per high-
powered field. The percentage of adherent cells that transmigrated below
the endothelial layer was called percentage of transendothelial migration.
Immunoprecipitation and Western blot. Tissue culture plates (Prima-
ria, Falcon) were coated with 3 ml of FBS in 5% CO2 at 37 C for at least
1 h and washed twice with 0.9% saline. Neutrophils (15   106) were added
to each plate containing 4 ml of reaction mixture, incubated with each
compound at 37 C for 30 min, and stimulated with buffer control or TNF
(100 ng/ml). When cells were spread fully (20–40 min), they were treated
with 5 mM diisopropylfluorophosphate to inhibit serine proteases, and lysed
with 125  l of SDS lysis buffer (10 mM Tris-HCl, pH 7.6; 150 mM NaCl;
1% SDS; 1 mM PMSF; 1 mM Na pyrophosphate; 1 mM NaF; 1 mM vana-
date; 5  g/ml each of aprotinin, leupeptin, chymostatin, pepstatin A) for
Western blot or with 200  l of nondenaturing modified radioimmunopre-
cipitation assay buffer (10 mM Tris-HCl, pH 7.6; 150 mM NaCl; 1% Tri-
ton X-100; 1 mM PMSF; 1 mM Na pyrophosphate; 1 mM NaF; 1 mM
vanadate; 5  g/ml each of aprotinin, leupeptin, chymostatin, pepstatin A)
for immunoprecipitation. The cell lysate was passed through a 26-gauge
needle six times to shear DNA, and centrifuged at 20,000 g for 15 min to
remove cell debris and DNA. The protein concentration was determined
using a Bio-Rad kit. Cell lysates were separated by SDS-PAGE and trans-
ferred electrophoretically to nitrocellulose membranes (Schleicher &
Schuell, Inc.). The membranes were incubated with 5% milk in TBST (100
mM Tris-HCl, pH 7.5; 9% NaCl; 0.1% Tween-20) for 1 h at 37 C, and
then overnight at 4 C with antiphosphotyrosine antibody (Santa Cruz Bio-
technology, Inc.), anti-Syk antibody (Transduction Laboratories), antiphos-
pho-specific Pyk2 antibodies (Biosource International), or anti-Pyk2 anti-
body (Upstate Biotechnology). sAC protein was immunoblotted with
monoclonal antibody R21 and immunostained with monoclonal antibodies
R21, R41, and R52 produced in the laboratories of two of us (L. Levin and
J. Buck). Membranes were washed with TBST and incubated with second-
ary antibody conjugated with horseradish peroxidase in 5% milk in TBST
for 1 h at 37 C. After further washing with TBST, bound antibody was de-
tected by enhanced chemiluminescence (Pierce Chemical Co.).
In vitro kinase assay for Src and Syk. Kinase assays were performed
according to the instructions provided by UBI, from which recombinant
Src and Syk were purchased. In brief, after incubation of recombinant Src
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action buffer (100 mM Tris-HCl, pH 7.2; 125 mM MgCl2; 25 mM MnCl2;
2 mM EGTA; 0.25 mM NaVO4; 2 mM DTT), Src kinase substrate peptide
(375  M) and [ -32P]ATP were added to the reaction mixture. After incu-
bation at 30 C for 10 min, the reaction was stopped by addition of 40%
TCA. After transferring each sample to a P81 paper square (UBI), unincor-
porated radioactivity was washed off with 0.75% phosphoric acid and ace-
tone, and the assay square was read in a scintillation counter. For Syk kinase
assay, reaction buffer contained 50 mM Tris-HCl, pH 7.5; 0.1 mM EGTA;
0.1 mM NaVO4; 0.15 M 2-mercaptoethanol and substrate was poly (Glu4-
Tyr); 4:1; (CSI Biointernational). Each condition was done in duplicate.
Translocation of p47phox. Neutrophil lysates were prepared as above
with 2.5% Triton X-100 lysis buffer (final concentration of 1% Triton
X-100 after dilution in plate with residual KRPG). The cell lysate was
passed through a 26-gauge needle six times to shear DNA and centrifuged
at 20,000 g for 15 min to remove cell debris and DNA. The supernatant was
centrifuged again at 100,000 g for 1 h to pellet membrane fraction. The pel-
let was washed with PBS and resuspended in 2% Triton X-100 lysis buffer.
Membrane fraction from each condition was separated by SDS-PAGE and
Western blotted with anti-p47phox Ab (a gift from T. Leto, National Insti-
tutes of Health, Bethesda, MD; reference 36).
cAMP accumulation assay. Neutrophils (5   106/well) were plated in
FBS-coated 24-well tissue culture plates (Corning) in 500  l of KRPG.
The cells were pretreated with 3-isobutyl-1-methylxanthine (100  M), and
2 (5  M) or KH7 (25  M) for 30 min. Ionomycin (1  M, Sigma-Aldrich)
was added to each well to stimulate calcium release, and cAMP was allowed
to accumulate for 0 or 2 min at 37 C. The assay was stopped, cells were
lysed by adding 500  l of 0.2 N HCl, and cAMP concentration was deter-
mined using the Correlate-EIA Direct cAMP Kit (Assay Designs, Inc.).
Rap1 activation assay. Lysates of neutrophils that had been pretreated
for 30 min with DMSO, 2, KH7 (25  M), or ddAdo (25  M; Calbiochem;
reference 37) and then stimulated for 30 min with TNF or buffer alone
were incubated with agarose beads coupled to recombinant RalGDS-Rap
binding domain to affinity purify GTP-bound Rap1. Beads were boiled in
SDS sample buffer and the supernate was subjected to SDS-PAGE and
Western blot with anti Rap1 antibody (Santa Cruz Biotechnology, Inc.).
Western blot of total cell lysates served as a control for equal input into the
Rap binding domain affinity purification.
Immunofluorescence staining of sAC in human neutrophils. Neu-
trophils were fixed and permeabilized with 3.3% paraformaldehyde, 0.05%
glutaraldehyde, and 0.25 mg/ml saponin in PBS for 5 min at room tempera-
ture. The reactions were stopped with the same volume of 20 mM glycine
buffer. The cells were washed three times with PBS. After permeabilization,
cells were blocked in 2% BSA for at least 1 h. Cells were stained with biotin-
conjugated anti-sAC (R21, R41, or R52) monoclonal antibody (1:250) over-
night in 2% BSA, 0.01% Triton X-100; washed five times in 2% BSA; stained
for 45 min with streptavidin Alexa Fluor 594 (Molecular Probes) in 2% BSA,
0.01% Triton X-100; and mounted with gelvatol/diaminobicyclooctane
(Sigma-Aldrich). Fluorescent images were recorded by a digital camera
(Hamamatsu) connected to an inverted epifluorescent microscope (Nikon).
Determination of neutrophil intracellular free Ca2  ([Ca2 ]i).   The
Ca2 -sensitive fluorescent probe Fluo-3/AM (Molecular Probes) was used
for determination of changes in [Ca2 ]i. Neutrophils were incubated in the
dark for 40 min at room temperature with Fluo-3/AM (10  M) in M199
(GIBCO BRL) containing 0.025% pluronic acid, 2.5 mM probenecid,
0.5% human serum albumin, and 20 mM Hepes. Cells were washed twice
and incubated with M199 containing 2.5 mM probenecid, 0.5% human se-
rum albumin, and 20 mM Hepes in the dark for 20 min at room tempera-
ture to allow hydrolysis of the dye ester. 105 PMN with DMSO, 2, or KH7
were plated in 35-mm glass-bottomed coverslip dishes (Mat Tek Corpora-
tion) precoated with FBS, and allowed to settle for 10 min. Changes in
neutrophil [Ca2 ]i in response to TNF (100 ng/ml) or ionomycin (1  M)
were measured using a Zeiss Axiovert 200M wide-field microscope. Digi-
tized images were captured every 5 s before and after TNF stimulation
through a charge-coupled device camera controlled by MetaMorph soft-
ware (Universal Imaging). Quantitative analysis of images was performed
with MetaMorph software. In brief, after background subtraction, the total
averaged intensity per field was measured per time point. Relative fluores-
cence intensities per field for each time point were plotted.
Online supplemental material. Figs. S1–S3 illustrate the impact of 2 on
bacterial killing by neutrophils, the interaction of neutrophils with TNF-
activated HUVEC monolayers, and the impact of inhibitors on biochemical
events involved in TNF-induced activation of adherent neutrophils. Online
supplemental material is available at http://www.jem.org/cgi/content/full/
jem.20050778/DC1.
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